Login / Signup

A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.

Elias JabbourNicholas James ShortFarhad RavandiXuelin HuangLianchun XiaoGuillermo Garcia-ManeroWilliam PlunkettVarsha GandhiKoiji SasakiNaveen PemmarajuNaval G DaverGautam BorthakurNitin JainMarina KonoplevaZeev EstrovTapan Mahendra KadiaWilliam G WierdaCourtney D DiNardoMark BrandtSusan M O'BrienJorge E CortesHagop Kantarjian
Published in: Cancer (2017)
CIA and FIA have similar efficacy in younger patients with newly diagnosed AML, although FIA is associated with a better toxicity profile. Cancer 2017;123:4430-9. © 2017 American Cancer Society.
Keyphrases
  • acute myeloid leukemia
  • newly diagnosed
  • papillary thyroid
  • squamous cell
  • oxidative stress
  • high dose
  • clinical trial
  • squamous cell carcinoma
  • low dose
  • acute lymphoblastic leukemia
  • young adults